NCT05248581Recruiting
Living Donor Liver Transplant for Unresectable Colorectal Liver Metastases
Liver Transplantation From Living Donors For Treatment Of Non-Resectable Colorectal Carcinoma Liver Metastases: A Registry Study
Source: ClinicalTrials.gov · Last updated 20 Jul 2026
Brief summary (registry, in English)
The goal of this study is to create a data registry to capture clinical, pathologic, and molecular data/outcomes for patients with metastatic colorectal cancer who undergo live donor liver transplantation.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 25 (estimated)
- First submitted
- 9 Feb 2022
- Start date
- Aug 2019
- Primary completion date
- Aug 2027
- Lead sponsor
- University of Rochester
- NCT number
- NCT05248581
What you commit to
- Study type: Observational
- Planned participants: 25
- From Aug 2019 to the primary completion date, Aug 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Not a candidate of the LDLT liver transplant protocol for treatment of colorectal liver metastasis.
Other
- Unwilling to consent
Who the study is looking for
- Age ≥ 18
- Non-amenable to curative hepatic resection as defined by FLR \<30%
- Histologically confirmed adenocarcinoma of the colon or rectum
- Candidate for LDLT for colorectal liver metastasis per the University of Rochester liver transplant program
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Rochester Medical Center Coordinator of this site? Confirm its status | Rochester | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.